Filing Overview
Medirom Healthcare Technologies Inc. filed a Form 6-K for January 2023 on January 18, 2023. The filing furnished two press releases covering unaudited, preliminary financial results for the year ended December 31, 2022, prepared under Japanese GAAP, and key performance indicators for December 2022.
Financial Results and Key Metrics
The filing text does not provide the underlying revenue, profit, cash flow, margin, debt, liquidity, or KPI values. These details are contained in Exhibits 99.1 and 99.2, which were furnished with the Form 6-K.
Material Changes Versus Prior Period
The filing announces the release of full-year 2022 preliminary financial results and December 2022 KPIs, but does not state the period-over-period changes or comparative amounts.
Guidance, Outlook, Risks, and Unusual Items
- The financial results and management estimates are unreviewed, unaudited, and preliminary.
- The results were prepared solely under Japanese GAAP and have not been reviewed or audited under U.S. GAAP.
- Actual results may differ following management’s financial closing procedures, reconciliations, adjustments, and the independent audit under U.S. GAAP.
- Management estimates are based on information and assumptions available as of January 18, 2023 and remain subject to change.
- The company cautioned investors not to place undue reliance on the preliminary information.
- The exhibits were furnished, not filed, and are not subject to liability under Section 18 of the Securities Exchange Act.
Key Facts to Verify
- Verify the full-year 2022 revenue, operating income, net income, cash flow, margins, debt, and liquidity figures in Exhibit 99.1.
- Verify the December 2022 KPIs and their definitions in Exhibit 99.2.
- Compare the preliminary JGAAP figures with the final audited U.S. GAAP results when available.
- Review any audit adjustments, reconciliations, or changes to management estimates.